These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 5581538)
1. Comparison of the progress of flat new vessels on the optic disc with those on the retina in patients treated by pituitary ablation. Elkeles RS; Blach RK; Joplin GF Diabetologia; 1971 Apr; 7(2):102-6. PubMed ID: 5581538 [No Abstract] [Full Text] [Related]
2. The rate of formation and disapearance of microaneurysms i diabetic retinopathy. Kohner EM; Dollery CT Eur J Clin Invest; 1970 Nov; 1(3):167-71. PubMed ID: 5497219 [No Abstract] [Full Text] [Related]
3. Diabetic retinopathy: new vessels arising from the optic disc. II. Response to pituitary ablation by yttrium 90 implant. Panisset A; Kohner EM; Cheng H; Fraser TR Diabetes; 1971 Dec; 20(12):824-33. PubMed ID: 5120325 [No Abstract] [Full Text] [Related]
4. Diabetic retinopathy. II. Comparison of disease remission induced by various degrees of pituitary ablation by Y90. Joplin GF; Oakley NW; Hill DW; Kohner EM; Fraser TR Diabetologia; 1967 Aug; 3(4):406-12. PubMed ID: 5620799 [No Abstract] [Full Text] [Related]
5. Treatment of proliferative diabetic retinopathy by light coagulation. Dobree JH; Taylor E Trans Ophthalmol Soc U K (1962); 1969; 88():313-29. PubMed ID: 5272258 [No Abstract] [Full Text] [Related]
7. Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10. Rand LI; Prud'homme GJ; Ederer F; Canner PL Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):983-91. PubMed ID: 2409053 [TBL] [Abstract][Full Text] [Related]
8. Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation. Wright AD; Kohner EM; Oakley NW; Hartog M; Joplin GF; Fraser TR Br Med J; 1969 May; 2(5653):346-8. PubMed ID: 5768460 [TBL] [Abstract][Full Text] [Related]
9. Natural history of peripheral neovascularisation in diabetic retinopathy. Turner GS; Inglesby DV; Sharriff B; Kohner EM Br J Ophthalmol; 1985 Jun; 69(6):420-4. PubMed ID: 2408660 [TBL] [Abstract][Full Text] [Related]
10. The retina and optic nerve. L'Esperance FA Arch Ophthalmol; 1969 Jul; 82(1):112-36. PubMed ID: 4894512 [No Abstract] [Full Text] [Related]
11. Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laser. Hercules BL; Gayed II; Lucas SB; Jeacock J Br J Ophthalmol; 1977 Sep; 61(9):555-63. PubMed ID: 336079 [TBL] [Abstract][Full Text] [Related]
12. Photocoagulation for diabetic retinopathy. Irvine AR; Norton EW Mod Probl Ophthalmol; 1972; 10():596-608. PubMed ID: 5056373 [No Abstract] [Full Text] [Related]
13. Effect of pituitary ablation on diabetic retinopathy studied by fluorescence angiography. Kohner EM; Dollery CT; Fraser TR; Bulpitt CJ Diabetes; 1970 Oct; 19(10):703-14. PubMed ID: 5474207 [No Abstract] [Full Text] [Related]
14. Pituitary ablation by yttrium-90 implants for diabetic retinopathy. FRASER R; JOPLIN GF; STEINER RE Diabetes; 1962; 11():482-3. PubMed ID: 13959343 [No Abstract] [Full Text] [Related]
16. The evolution and natural history of diabetic retinopathy. Kohner EM Int Ophthalmol Clin; 1978; 18(4):1-16. PubMed ID: 721378 [No Abstract] [Full Text] [Related]